KalVista Pharmaceuticals to Present HAE Attack Journey Data at 2023 US HAEA National Summit
KalVista Pharmaceuticals, Inc. , a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced the...
Source: marketscreener.com